DDX50

Across TCGA pan-cancer cohorts, DDX50 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of DDX50’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where DDX50 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types DDX50 is over-expressed in tumor.

COAD, LSCC, and LUAD are the cancer types where DDX50 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DDX50 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.429	<.001	11	view →
LSCC	Male	All	+0.571	<.001	9	view →
LUAD	Male	III,IV	+0.428	<.001	9	view →
HNSC	Male	III,IV	+0.397	<.001	8	view →
CCRCC	Male	III,IV	+0.167	<.001	6	view →
PDAC	Male	All	+0.249	<.001	4	view →
OV	All	All	+0.335	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

DDX50–COAD

Open the COAD breakdown →